Amplify Transformational Data Sharing ETF vs 10X Genomics Inc — how do they compare? Amplify Transformational Data Sharing ETF trades at $61.14, while 10X Genomics Inc trades at $45.85 (market cap $5.30B). The key difference: 10X Genomics Inc is trading nearer its 52-week high, Amplify Transformational Data Sharing ETF nearer its low. Which is the better fit depends on your goals.
| BLOK | TXG | |
|---|---|---|
52-Week High | $74.10 | $45.80 |
52-Week Low | $47.36 | $11.34 |
Market Cap | — | $5.30B |
Sector | — | Health |
Enterprise Value | — | $4.85B |
Signals from Pluang's Aura AI — not financial advice
BLOK trades at $60.81, down 2.95% on the day, with a bearish technical signal from moving averages while oscillators are neutral. The stock faces resistance near $62 and support at $60. Recent news highlights its diversified blockchain economy exposure, including miners and enterprise adopters, though financial ratios like P/E and P/S are not provided in the current dataset.
The outlook remains cautious due to technical bearishness and increased reliance on Bitcoin performance, posing volatility risks. Investment opportunity lies in broad blockchain sector exposure, but risks include market sentiment shifts and lack of near-term catalysts, warranting close monitoring of earnings and sector trends.
TXG trades at $41.77, down 2.25% today, with a bullish technical setup supported by moving averages. The company shows improving fundamentals with revenue growth to $642.82M in 2025 and narrowing losses, while recent collaborations with Cleveland Clinic and the Proteintech acquisition expand its diagnostic capabilities. Analyst sentiment is mixed with 45% buy ratings but a consensus price target below current levels.
The outlook suggests cautious optimism as TXG demonstrates operational improvement with positive cash flow generation, though profitability remains elusive. Key risks include execution challenges in new ventures and competitive pressures, while upside potential hinges on continued margin expansion and successful integration of recent acquisitions.
Trailing returns across standard periods
Latest headlines on both assets
The fund is an actively managed ETF that seeks to provide total return by investing at least 80% of its net assets in the equity securities of companies actively involved in the development and utilization of "transformational data sharing technologies". It may invest in non-US equity securities, including depositary receipts.
Read more on BLOK →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →